Get started
Author

Lieve M. Vandeplassche

Observed names: L Vandeplassche, L. VANDEPLASSCHE, L. Vandeplassche, Lieve Vandeplassche, Vandeplassche, L, Vandeplassche, L.
OpenAlex ID: A5085844739
A Placebo-Controlled Trial of Prucalopride for Severe Chronic Constipation
2008 · Michael Camilleri, René Kerstens, et al. · New England Journal of Medicine · 578
PDF
Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives
2008 · J Tack, M van Outryve, et al. · Gut · 347
Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation – a 12‐week, randomized, double‐blind, placebo‐controlled study
2008 · E. M. M. QUIGLEY, L. VANDEPLASSCHE, et al. · Alimentary Pharmacology & Therapeutics · 345
A double‐blind, placebo‐controlled study of prucalopride in elderly patients with chronic constipation
2010 · S. Müller‐lissner, A. Rykx, et al. · Neurogastroenterology & Motility · 134
Safety assessment of prucalopride in elderly patients with constipation: a double‐blind, placebo‐controlled study
2009 · M. Camilleri, G. Beyens, et al. · Neurogastroenterology & Motility · 133
PDF
Randomised clinical trial: the efficacy of prucalopride in patients with chronic intestinal pseudo‐obstruction – a double‐blind, placebo‐controlled, cross‐over, multiple n = 1 study
2011 · A. V. Emmanuel, M. A. Kamm, et al. · Alimentary Pharmacology & Therapeutics · 114
PDF
Clinical trial: the efficacy of open‐label prucalopride treatment in patients with chronic constipation – follow‐up of patients from the pivotal studies
2010 · M. Camilleri, M. J. Van Outryve, et al. · Alimentary Pharmacology & Therapeutics · 97
Effect of prucalopride on symptoms of chronic constipation
2013 · J. Tack, V. Stanghellini, et al. · Neurogastroenterology & Motility · 80
PDF
Oral Prucalopride in Children With Functional Constipation
2013 · Harland S. Winter, Carlo Di Lorenzo, et al. · Journal of Pediatric Gastroenterology and Nutrition · 78
Prucalopride Improves Bowel Function and Colonic Transit Time in Patients With Chronic Constipation: An Integrated Analysis
2014 · Anton Emmanuel, Marina Cools, et al. · The American Journal of Gastroenterology · 73
Assessment of the cardiac safety of prucalopride in healthy volunteers: a randomized, double‐blind, placebo‐ and positive‐controlled thorough QT study
2011 · Boaz Mendzelevski, Jannie Ausma, et al. · British Journal of Clinical Pharmacology · 71
PDF
Efficacy and safety of oral prucalopride in women with chronic constipation in whom laxatives have failed: an integrated analysis
2013 · Jan Tack, Eamonn Quigley, et al. · United European Gastroenterology Journal · 49
PDF
Association between health‐related quality of life and symptoms in patients with chronic constipation: an integrated analysis of three phase 3 trials of prucalopride
2015 · J. Tack, M. Camilleri, et al. · Neurogastroenterology & Motility · 47
PDF
Factors affecting satisfaction with treatment in European women with chronic constipation: An internet survey
2013 · Anton Emmanuel, Eamonn MM Quigley, et al. · United European Gastroenterology Journal · 37
PDF
Activity of the Triazole Antifungal R126638 as Assessed by Corneofungimetry
2005 · C. Piérard-Franchimont, J. Ausma, et al. · Skin Pharmacology and Physiology · 29
Effect of renal impairment on the pharmacokinetics of prucalopride: a single- dose open-label Phase I study
2012 · Lieve Vandeplassche, Smith, et al. · Drug Design Development and Therapy · 27
PDF
934 Evaluation of the Efficacy, Safety and Tolerability of Prucalopride (Resolor®) Given Subcutaneously in Patients Undergoing Elective Partial Colectomies
2008 · Susan Galandiuk, Greet Beyens, et al. · Gastroenterology · 19
Effect of Prucalopride on the Pharmacokinetics of Oral Contraceptives in Healthy Women
2013 · Vera Van de Velde, Lieve Vandeplassche, et al. · Drugs in R&D · 14
PDF
T1265 Cardiovascular Safety of Prucalopride in Healthy Subjects: Results from Two Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trials
2009 · Malcolm J. Boyce, Rene Kerstens, et al. · Gastroenterology · 13
The efficacy of oral treatment with pramiconazole in pityriasis versicolor: a phase II a trial
2007 · J. Faergemann, J. Ausma, et al. · British Journal of Dermatology · 11
T1322 Safety and Tolerability of Prucalopride (Resolor®) in Patients with Chronic Constipation: Pooled Data from Three Pivotal Phase III Studies
2008 · Jan F. Tack, Jannie Ausma, et al. · Gastroenterology · 10
Effects of R 56865 and Phenytoin on Mechanical, Biochemical, and Morphologic Changes During Ouabain Intoxication in Isolated Perfused Rabbit Heart
1992 · F. Tegtmeier, D. Wilhelm, et al. · Journal of Cardiovascular Pharmacology · 10
T1402 Efficacy of 12-Week Treatment with Prucalopride (Resolor®) in Patients with Chronic Constipation: Combined Results of Three Identical Randomized, Double-Blind, Placebo-Controlled Phase III Trials
2008 · Michael Camilleri, Renate Specht Gryp, et al. · Gastroenterology · 9
T1270 Food Does Not Affect the Oral Bioavailability of Prucalopride
2009 · Vera J. Van de Velde, Jannie Ausma, et al. · Gastroenterology · 8
1052 Randomized Double-Blind Placebo-Controlled Trial to Evaluate Efficacy and Safety of Prucalopride (Resolor®) in Elderly Patients with Chronic Constipation
2008 · Stefan A. Mueller-Lissner, An Rykx, et al. · Gastroenterology · 8
Works count: 51
Citation count: 2,419
H-index: 17
I10-index: 22
Year
Topic
Type